Erectile Dysfunction (ED)
Erectile dysfunction of vascular origin is the result of impaired arterial inflow and endothelial dysfunction in the penile microvasculature — the same pathological substrate addressed by Li-ESWT. Focused shockwaves applied to the corpus cavernosum and crura penis stimulate neoangiogenesis, restore endothelial function through eNOS upregulation, and activate Schwann cell proliferation in cases with neurogenic components.
The mechanism is not analgesic or symptomatic. Li-ESWT regenerates the vascular architecture of the penis — addressing the structural cause of ED rather than circumventing it. The clinical implications are significant: responders achieve functional erections without pharmacological support, and a meaningful subset of patients experience durable improvement beyond the active treatment course.
A systematic review of 14 studies (N=833) concluded that Li-ESWT “may have the potential to become the first-line non-invasive treatment for ED patients” (Lu et al., European Urology, 2016). A prospective RCT (Olsen et al., 2014) demonstrated that 57% of men treated with Li-ESWT achieved satisfactory erections without medication after therapy. An Australian open-label study (Chung, BJU International, 2015) reported IIEF-5 improvement ≥5 points in 60% of patients; 67% reported satisfaction level 4/5; 80% would recommend the treatment to others.
